Most Active Stories
- Rally To Be Held At Arkansas Capitol Challenging Incarceration Policies
- Is Open Carry Legal in Arkansas? Depends On Who You Ask.
- Arkansas Herpetologist, University of Tulsa Researcher Find New Species
- Old State House To Screen "White Lightning" - 1973 Movie Shot In Arkansas
- Poll: Ross, Hutchinson In Virtual Dead Heat In Governor’s Race
Local & Regional News
Wed May 15, 2013
Arkansas Correction Agency Loses Drug Company Account
The Arkansas Department of Correction says a pharmaceutical company has closed its account after the state last month acknowledged plans to use its anti-seizure drug phenobarbital in executions.
Department of Correction spokeswoman Shea Wilson told The Associated Press that West-Ward Pharmaceuticals officials notified the agency Wednesday that the company was closing the prison system's account.
The agency said last month that it would use phenobarbital in executions, even though the barbiturate has never been used in U.S. lethal injections.
West-Ward's London-based parent company, Hikma Pharmaceuticals, said Wednesday that it objects to its products' use in capital punishment.
Hikma also said it would no longer sell injectable phenobarbital directly to U.S. corrections departments.
However, Hikma spokesman Matthew Cole would not discuss specifics about Arkansas' account. Arkansas doesn't have any pending executions.